PPARG Human

Peroxisome Proliferator Activated Receptor Gamma Human Recombinant
Cat. No.
BT1536
Source
Escherichia Coli.
Synonyms
Peroxisome proliferator-activated receptor gamma, PPAR-gamma, PPARG, NR1C3, PPARG1, PPARG2.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Peroxisome Proliferator Activated Receptor Gamma Human Recombinant is expressed in E.coli having a molecular weight of 59.2 kDa and fused to an amino terminal hexahistidine tag.

Product Specs

Introduction
The peroxisome proliferator-activated receptors (PPARs) are a group of ligand-activated transcription factors belonging to the nuclear receptor superfamily. They play crucial roles in adipogenesis, glucose homeostasis, and inflammation. There are three distinct isotypes: alpha, beta (also known as delta), and gamma. PPAR gamma is predominantly expressed in adipose tissue, with lower levels found in the colon, immune system, and retina. While PPAR alpha is involved in fatty acid catabolism in the liver, PPAR gamma regulates fatty acid storage in adipose tissue and contributes to adipocyte differentiation. PPAR gamma forms a heterodimer with retinoid X receptor (RXR) to bind to DNA. This binding, upon ligand activation, initiates the expression of target genes.
Description
Recombinant Human Peroxisome Proliferator Activated Receptor Gamma is produced in E. coli. It has a molecular weight of 59.2 kDa and includes an amino-terminal hexahistidine tag.
Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation
The protein is supplied in a solution containing 20mM Tris-HCl buffer and 50% glycerol.
Stability
For short-term storage (2-4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Repeated freezing and thawing should be avoided.
Purity
The purity of the protein is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
Peroxisome proliferator-activated receptor gamma, PPAR-gamma, PPARG, NR1C3, PPARG1, PPARG2.
Source
Escherichia Coli.

Product Science Overview

Introduction

Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) is a ligand-activated nuclear receptor that plays a crucial role in the regulation of lipid and glucose homeostasis, inflammation, and cellular differentiation . It is a member of the nuclear receptor family and is involved in various physiological processes, including adipogenesis, insulin sensitivity, and vascular homeostasis .

Discovery and Structure

PPAR-γ was first identified in the early 1990s and has since been extensively studied for its role in adipocyte differentiation, maintenance, and function . The receptor has four functional domains: the N-terminal A/B domain, the DNA binding domain (DBD), the hinge domain, and the C-terminal ligand binding domain (LBD) . The LBD is responsible for ligand specificity and is crucial for homo- or hetero-dimerization, allowing interaction with co-repressors, coactivators, and other cofactors .

Mechanism of Action

PPAR-γ acts through the formation of heterodimers with retinoid X receptors (RXRs) to modify target gene expression at the transcriptional level in response to endogenous or synthetic ligands . When activated by its ligand, PPAR-γ can interact with specific DNA response elements to control gene transcription and expression . This regulation is essential for lipid metabolism, improving insulin sensitivity, modulating antitumor mechanisms, reducing oxidative stress, and inhibiting inflammation .

Therapeutic Potential

PPAR-γ has been shown to have significant therapeutic potential in various medical conditions. It has been studied for its neuroprotective effects in cerebral ischemic injury, where it helps prevent post-ischemic inflammation and neuronal damage . Additionally, PPAR-γ agonists have shown therapeutic effects in kidney conditions and various cancers . However, the associated side effects of synthetic agonists restrict their widespread use .

Recombinant Human PPAR-γ

Recombinant human PPAR-γ is produced using molecular cloning and transient expression techniques. One such method involves the use of an inducible Tet-On 3G system in human embryonic kidney 293T (HEK293T) cells . This system allows for high expression levels of PPAR-γ, making it a valuable model for studying the receptor’s function and potential therapeutic applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.